Literature DB >> 11771761

Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure.

R Weitzdoerfer1, M Dierssen, M Fountoulakis, G Lubec.   

Abstract

Information on fetal brain in Down Syndrome (DS) is limited and there are only few histological, mainly anecdotal reports and no systematic study on the wiring of the brain in early prenatal life exists. Histological methods are also hampered by inherent problems of morphometry of neuronal structures. It was therefore the aim of the study to evaluate neuronal loss, synaptic structures and dendritic spines in the fetus with Down Syndrome as compared to controls by biochemical measurements. 2 dimensional electrophoresis with subsequent mass spectroscopical identification of spots and their quantification with specific software was selected. This technique identifies proteins unambiguously and concomitantly on the same gel. Fetal cortex samples were taken at autopsy with low post-mortem time, homogenized and neuron specific enolase (NSE) determined as a marker for neuronal density, the synaptosomal associated proteins alpha SNAP [soluble N-ethylmaleimide-sensitive fusion (NSF) attachment protein], beta SNAP, SNAP 25 and the channel associated protein of synapse 110 (chapsyn 110) as markers for synaptosomal structures and drebrin (DRB) as marker for dendritic spines. NSE, chapsyn 110 and beta SNAP were comparable in the control fetus panel and in Down Syndrome fetuses. Drebrin was significantly and remarkably reduced and not even detectable in several Down Syndrome brain samples. Quantification of SNAP 25 revealed significantly reduced values in DS cortex and alpha SNAP was only present in half of the DS individuals. We conclude that at the time point of about 19 weeks of gestation (early second trimester) no neuronal loss can be detected but drebrin, a marker for dendritic spines and synaptosomal associated proteins alpha SNAP and SNAP 25 were significantly reduced indicating impaired synaptogenesis. Early dendritic deterioration maybe leading to the degeneration of the dendritic tree and arborization, which is a hallmark of Down Syndrome from infancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11771761     DOI: 10.1007/978-3-7091-6262-0_5

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  39 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression.

Authors:  Norihisa Ooe; Koichi Saito; Nobuyoshi Mikami; Iwao Nakatuka; Hideo Kaneko
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

3.  The actin-binding domain of spinophilin is necessary and sufficient for targeting to dendritic spines.

Authors:  Stacie D Grossman; Linda C Hsieh-Wilson; Patrick B Allen; Angus C Nairn; Paul Greengard
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

5.  Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.

Authors:  Karol Dowjat; Tatyana Adayev; Wojciech Kaczmarski; Jerzy Wegiel; Yu-Wen Hwang
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

6.  N-ethylmaleimide-sensitive factor attachment protein α (αSNAP) regulates matrix adhesion and integrin processing in human epithelial cells.

Authors:  Nayden G Naydenov; Alex Feygin; Lifu Wang; Andrei I Ivanov
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

7.  Association of Alpha-Soluble NSF Attachment Protein with Epileptic Seizure.

Authors:  Zhiqin Xi; Wanni Deng; Liang Wang; Fei Xiao; Jie Li; Zhihua Wang; Xin Wang; Xiujuan Mi; Na Wang; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

8.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

10.  Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.

Authors:  R L Nosheny; P V Belichenko; B L Busse; A M Weissmiller; V Dang; D Das; A Fahimi; A Salehi; S J Smith; W C Mobley
Journal:  Neurobiol Dis       Date:  2015-03-06       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.